Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

NCT01405846 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

32

Enrollment

OTHER_GOV

Sponsor class

Stopped Futility

Conditions

Lung Cancer
Head and Neck Cancer

Interventions

DRUG: Gefitinib

Sponsor

Papworth Hospital NHS Foundation Trust

Collaborators

[object Object]
[object Object]